Product Code: ETC13371209 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Veterinary CRO CDMO Market was valued at USD 1.3 Billion in 2024 and is expected to reach USD 2.1 Billion by 2031, growing at a compound annual growth rate of 7.90% during the forecast period (2025-2031).
The Global Veterinary CRO CDMO (Contract Research Organization and Contract Development and Manufacturing Organization) Market is witnessing steady growth due to the increasing demand for specialized services in the veterinary pharmaceutical and biotechnology industry. These organizations offer a range of services such as preclinical research, clinical trials, regulatory support, and manufacturing of veterinary drugs. Key factors driving the market include the rising prevalence of animal diseases, growing pet adoption rates, and a surge in investments in animal health research. Additionally, advancements in technology, increasing awareness about animal healthcare, and a shift towards personalized medicine for animals are also contributing to the market`s expansion. Major players in the industry are focusing on strategic collaborations, acquisitions, and partnerships to enhance their service offerings and expand their global presence.
The Global Veterinary CRO CDMO market is witnessing significant growth driven by the increasing demand for specialized services in animal health research and development. Key trends include a rising focus on personalized medicine for pets, advancements in biotechnology leading to innovative treatments, and the shift towards outsourcing to streamline operations and reduce costs. Opportunities in the market lie in the expansion of services to cater to the growing number of companion animals, investment in cutting-edge technologies like genomics and data analytics for better outcomes, and strategic partnerships with pharmaceutical companies for collaborative research projects. Overall, the market is poised for continued growth as the importance of animal health research and development gains prominence worldwide.
Some key challenges faced in the Global Veterinary CRO CDMO (Contract Research Organization and Contract Development and Manufacturing Organization) market include regulatory complexities and stringent guidelines specific to animal health products, limited awareness and adoption of CRO CDMO services among veterinary companies, the need for specialized expertise in both veterinary medicine and research methodology, and the high cost associated with conducting clinical trials and developing new products for the animal health industry. Additionally, competition from in-house research and development capabilities within veterinary companies, as well as the increasing trend of consolidation among CRO CDMO service providers, pose challenges for market growth and differentiation. In order to navigate these challenges, companies in the Global Veterinary CRO CDMO market need to invest in regulatory compliance, enhance collaboration with veterinary companies, and continuously innovate to meet the evolving demands of the industry.
The Global Veterinary CRO CDMO market is being primarily driven by factors such as the increasing demand for specialized services and expertise in the development of veterinary pharmaceuticals and biologics. The growing prevalence of animal diseases, coupled with the rising pet ownership and expenditure on animal healthcare, is fueling the need for outsourced research and manufacturing services in the veterinary sector. Additionally, the complexity of regulatory requirements and the need for cost-effective drug development processes are prompting veterinary companies to engage with specialized Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs). Furthermore, advancements in technology, such as personalized medicine and genomics, are further driving the growth of the market by offering innovative solutions for the development of veterinary therapeutics.
Government policies related to the Global Veterinary CRO CDMO Market primarily focus on ensuring the safety, efficacy, and quality of veterinary drugs and products. Regulatory bodies such as the FDA and EMA have stringent guidelines in place to govern the testing, approval, and manufacturing processes within the veterinary CRO CDMO industry. These policies aim to protect animal health, prevent the spread of diseases, and safeguard the environment from potential hazards. Additionally, governments may offer incentives or grants to promote research and development in the field of veterinary CRO CDMO, encouraging innovation and technological advancements. Compliance with these regulations is essential for companies operating in this market to maintain credibility, trust, and market access.
The Global Veterinary CRO CDMO (Contract Research Organization and Contract Development and Manufacturing Organization) market is expected to witness significant growth in the coming years due to the increasing demand for specialized services in the animal health industry. The market is driven by factors such as the rising prevalence of animal diseases, the growing focus on pet health and wellness, and the need for innovative and efficient drug development processes. Additionally, advancements in veterinary medicine, increased R&D investments, and collaborations between key players are expected to further propel market growth. With the expansion of the global pet care market and the increasing adoption of pets worldwide, the Veterinary CRO CDMO market is poised for substantial growth, offering lucrative opportunities for market players to capitalize on the evolving needs of the veterinary industry.
In the Global Veterinary CRO CDMO Market, Asia is projected to witness significant growth due to the increasing pet ownership and adoption of companion animals in countries like China and India. North America is expected to dominate the market, driven by the strong presence of key players, advanced healthcare infrastructure, and high pet healthcare expenditure. Europe is also a key market with a growing emphasis on animal welfare and increasing demand for specialized veterinary services. In the Middle East and Africa region, the market is poised for growth as urbanization leads to a rise in pet ownership and awareness about animal health. Latin America is experiencing steady growth attributed to the rising disposable income and changing perception towards pet healthcare, leading to increased demand for veterinary services and CRO CDMO solutions.
Global Veterinary CRO CDMO Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Veterinary CRO CDMO Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Veterinary CRO CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Global Veterinary CRO CDMO Market - Industry Life Cycle |
3.4 Global Veterinary CRO CDMO Market - Porter's Five Forces |
3.5 Global Veterinary CRO CDMO Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Veterinary CRO CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.7 Global Veterinary CRO CDMO Market Revenues & Volume Share, By Drug Development Stage, 2021 & 2031F |
3.8 Global Veterinary CRO CDMO Market Revenues & Volume Share, By Animal Type, 2021 & 2031F |
3.9 Global Veterinary CRO CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 Global Veterinary CRO CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Veterinary CRO CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Veterinary CRO CDMO Market Trends |
6 Global Veterinary CRO CDMO Market, 2021 - 2031 |
6.1 Global Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Veterinary CRO CDMO Market, Revenues & Volume, By Contract Research, 2021 - 2031 |
6.1.3 Global Veterinary CRO CDMO Market, Revenues & Volume, By Contract Manufacturing, 2021 - 2031 |
6.2 Global Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Veterinary CRO CDMO Market, Revenues & Volume, By Preclinical, 2021 - 2031 |
6.2.3 Global Veterinary CRO CDMO Market, Revenues & Volume, By Commercialization, 2021 - 2031 |
6.3 Global Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Veterinary CRO CDMO Market, Revenues & Volume, By Companion Animals, 2021 - 2031 |
6.3.3 Global Veterinary CRO CDMO Market, Revenues & Volume, By Livestock, 2021 - 2031 |
6.4 Global Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Veterinary CRO CDMO Market, Revenues & Volume, By Drug Testing, 2021 - 2031 |
6.4.3 Global Veterinary CRO CDMO Market, Revenues & Volume, By Vaccine Production, 2021 - 2031 |
6.5 Global Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Veterinary CRO CDMO Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.5.3 Global Veterinary CRO CDMO Market, Revenues & Volume, By Biotech Firms, 2021 - 2031 |
7 North America Veterinary CRO CDMO Market, Overview & Analysis |
7.1 North America Veterinary CRO CDMO Market Revenues & Volume, 2021 - 2031 |
7.2 North America Veterinary CRO CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.4 North America Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
7.5 North America Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
7.6 North America Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7 North America Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Veterinary CRO CDMO Market, Overview & Analysis |
8.1 Latin America (LATAM) Veterinary CRO CDMO Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Veterinary CRO CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
8.4 Latin America (LATAM) Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
8.5 Latin America (LATAM) Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
8.6 Latin America (LATAM) Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
8.7 Latin America (LATAM) Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Veterinary CRO CDMO Market, Overview & Analysis |
9.1 Asia Veterinary CRO CDMO Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Veterinary CRO CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
9.4 Asia Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
9.5 Asia Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
9.6 Asia Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
9.7 Asia Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Veterinary CRO CDMO Market, Overview & Analysis |
10.1 Africa Veterinary CRO CDMO Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Veterinary CRO CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
10.4 Africa Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
10.5 Africa Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
10.6 Africa Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
10.7 Africa Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Veterinary CRO CDMO Market, Overview & Analysis |
11.1 Europe Veterinary CRO CDMO Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Veterinary CRO CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
11.4 Europe Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
11.5 Europe Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
11.6 Europe Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
11.7 Europe Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Veterinary CRO CDMO Market, Overview & Analysis |
12.1 Middle East Veterinary CRO CDMO Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Veterinary CRO CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Veterinary CRO CDMO Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2021 - 2031 |
12.4 Middle East Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2021 - 2031 |
12.5 Middle East Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2021 - 2031 |
12.6 Middle East Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
12.7 Middle East Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Veterinary CRO CDMO Market Key Performance Indicators |
14 Global Veterinary CRO CDMO Market - Export/Import By Countries Assessment |
15 Global Veterinary CRO CDMO Market - Opportunity Assessment |
15.1 Global Veterinary CRO CDMO Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Veterinary CRO CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F |
15.3 Global Veterinary CRO CDMO Market Opportunity Assessment, By Drug Development Stage, 2021 & 2031F |
15.4 Global Veterinary CRO CDMO Market Opportunity Assessment, By Animal Type, 2021 & 2031F |
15.5 Global Veterinary CRO CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
15.6 Global Veterinary CRO CDMO Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Veterinary CRO CDMO Market - Competitive Landscape |
16.1 Global Veterinary CRO CDMO Market Revenue Share, By Companies, 2024 |
16.2 Global Veterinary CRO CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |